Dupilumab

• DUPIXENT 300 MG/ 2 ML ENJEKSIYONLUK COZELTI ICEREN KULLANIMA HAZIR ENJEKTOR (2 ADET IGNE KORUMASI OLAN)kode batang: 8699809951174

Tidak ada catatan makanan tercatat untuk zat aktif ini.

• AbciximabMODERAT

  Mengonsumsi Abciximab bersama Dupilumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abciximab is combined with Dupilumab.

• AdalimumabMODERAT

  Mengonsumsi Adalimumab bersama Dupilumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adalimumab is combined with Dupilumab.

• AdecatumumabMODERAT

  Mengonsumsi Adecatumumab bersama Dupilumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adecatumumab is combined with Dupilumab.

• AfelimomabMODERAT

  Mengonsumsi Afelimomab bersama Dupilumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Afelimomab is combined with Dupilumab.

• AlemtuzumabMODERAT

  Mengonsumsi Alemtuzumab bersama Dupilumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Dupilumab.

• AlirocumabMODERAT

  Mengonsumsi Alirocumab bersama Dupilumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alirocumab is combined with Dupilumab.

• AMG 108MODERAT

  Mengonsumsi AMG 108 bersama Dupilumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when AMG 108 is combined with Dupilumab.

• AnifrolumabMODERAT

  Mengonsumsi Anifrolumab bersama Dupilumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Anifrolumab is combined with Dupilumab.

• Anthrax immune globulin humanMODERAT

  Mengonsumsi Anthrax immune globulin human bersama Dupilumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Anthrax immune globulin human is combined with Dupilumab.

• Antilymphocyte immunoglobulin (horse)MODERAT

  Mengonsumsi Antilymphocyte immunoglobulin (horse) bersama Dupilumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Dupilumab.